代谢健康型肥胖与炎症因子的研究进展
Research Progress of Metabolically Healthy Obesity and Inflammatory Factors
DOI: 10.12677/ACM.2024.141076, PDF,  被引量   
作者: 许虎彪, 张 颖*：新疆医科大学第一附属医院干部保健中心综合内二科，新疆 乌鲁木齐
关键词: 肥胖；代谢健康型肥胖；炎症因子；Obesity； Metabolically Healthy Obesity； Inflammatory Factors
摘要: 肥胖所导致的慢性持续性低度炎症是胰岛素抵抗、2型糖尿病、心血管疾病发生发展的重要危险因素，然而有些肥胖个体表现出较好的新陈代谢特征，这种肥胖亚型被描述为“代谢健康肥胖”(MHO)。研究表明脂肪组织的慢性炎症可能是决定肥胖者代谢是否正常的关键性因素，MHO的生物学机制目前尚不明确，但可能与其有利的脂肪因子分泌模式有关。故本文就MHO与炎症因子的关系作一综述。
Abstract: The chronic and persistent low-grade inflammation caused by obesity is an important risk factor for the development of insulin resistance, type 2 diabetes, and cardiovascular disease. However, some obese individuals show better metabolic characteristics, and this subtype of obesity is described as “metabolically healthy obesity” (MHO). Studies have shown that chronic inflammation of adipose tissue may be a key factor in determining whether obese people have a normal metabolism. The bi-ological mechanism of MHO is still unclear, but it may be related to its favorable adipokine secretion pattern. Therefore, this article reviews the relationship between MHO and inflammatory factors.
文章引用：许虎彪, 张颖. 代谢健康型肥胖与炎症因子的研究进展[J]. 临床医学进展, 2024, 14(1): 546-551. https://doi.org/10.12677/ACM.2024.141076

参考文献

[1] Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E.C., Biryukov, S., Abbafati, C., Abera, S.F., et al. (2014) Global, Regional, and National Prevalence of Overweight and Obesity in Children and Adults during 1980-2013: A Systematic Analysis for the Global Burden of Disease Study 2013. The Lancet, 384, 766-781. [Google Scholar] [CrossRef] 
[2] Berrington de Gonzalez, A., Hartge, P., Cerhan, J.R., Flint, A.J., Hannan, L., MacInnis, R.J., Moore, S.C., Tobias, G.S., Anton-Culver, H., Freeman, L.B., Beeson, W.L., Clipp, S.L., English, D.R., Folsom, A.R., Freedman, D.M., Giles, G., Hakansson, N., Henderson, K.D., Hoffman-Bolton, J., Hoppin, J.A., Koenig, K.L., Lee, I.M., Linet, M.S., Park, Y., Pocobelli, G., Schatzkin, A., Sesso, H.D., Weiderpass, E., Willcox, B.J., Wolk, A., Zeleniuch-Jacquotte, A., Willett, W.C. and Thun, M.J. (2010) Body-Mass Index and Mortality among 1.46 Million White Adults. The New England Journal of Medicine, 363, 2211-2219. (Erratum in: N Engl J Med, 2011 Sep 1, 365(9): 869) [Google Scholar] [CrossRef] 
[3] 中国营养学会肥胖防控分会, 等. 中国居民肥胖防治专家共识[J]. 中国预防医学志, 2022, 23(5): 321-339. [Google Scholar] [CrossRef] 
[4] Safaei, M., Sundararajan, E.A., Driss, M., Boulila, W. and Shapi’i, A. (2021) A Systematic Literature Review on Obesity: Understanding the Causes & Consequences of Obesity and Reviewing Various Machine Learning Approaches Used to Predict Obesity. Computers in Biology and Medicine, 136, Article 104754. [Google Scholar] [CrossRef] [PubMed]
[5] Lee, Y.S., Wollam, J. and Olefsky, J.M. (2018) An Inte-grated View of Immunometabolism. Cell, 172, 22-40. [Google Scholar] [CrossRef] [PubMed]
[6] Blüher, M. (2020) Metabolically Healthy Obesity. Endocrine Re-views, 41, bnaa004. [Google Scholar] [CrossRef] [PubMed]
[7] Bala, C., Craciun, A.E. and Hancu, N. (2016) Updating the Concept of Metabolically Healthy Obesity. Acta Endocrinologica (Bucharest), 12, 197-205. [Google Scholar] [CrossRef] [PubMed]
[8] van Vliet-Ostaptchouk, J.V., Nuotio, M.L., Slagter, S.N., Doiron, D., Fischer, K., Foco, L., Gaye, A., Gögele, M., Heier, M., Hiekkalinna, T., Joensuu, A., Newby, C., Pang, C., Partinen, E., Reischl, E., Schwienbacher, C., Tammesoo, M.L., Swertz, M.A., Burton, P., Ferretti, V., Fortier, I., Giepmans, L., Harris, J.R., Hillege, H.L., Holmen, J., Jula, A., Kootstra-Ros, J.E., Kvaløy, K., Holmen, T.L., Männistö, S., Metspalu, A., Midthjell, K., Murtagh, M.J., Peters, A., Pramstaller, P.P., Saaristo, T., Salomaa, V., Stolk, R.P., Uusitupa, M., van der Harst, P., van der Klauw, M.M., Waldenberger, M., Perola, M. and Wolffenbuttel, B.H. (2014) The Prevalence of Meta-bolic Syndrome and Metabolically Healthy Obesity in Europe: A Collaborative Analysis of Ten Large Cohort Studies. BMC Endocrine Disorders, 14, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[9] Rey-López, J.P., de Rezende, L.F., Pastor-Valero, M. and Tess, B.H. (2014) The Prevalence of Metabolically Healthy Obesity: A Systematic Review and Critical Evaluation of the Definitions Used. Obesity Reviews, 15, 781-790. [Google Scholar] [CrossRef] [PubMed]
[10] Lavie, C.J., Laddu, D., Arena, R., Ortega, F.B., Alpert, M.A. and Kushner, R.F. (2018) Healthy Weight and Obesity Prevention: JACC Health Promotion Series. Journal of the American College of Cardiology, 72, 1506-1531. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, J.I., Huh, J.Y., Sohn, J.H., Choe, S.S., Lee, Y.S., Lim, C.Y., Jo, A., Park, S.B., Han, W. and Kim, J.B. (2015) Lipid-Overloaded Enlarged Adipocytes Provoke Insulin Resistance In-dependent of Inflammation. Molecular and Cellular Biology, 35, 1686-1699. [Google Scholar] [CrossRef] 
[12] Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L. and Spiegel-man, B.M. (1995) Increased Adipose Tissue Expression of Tumor Necrosis Factor-Alpha in Human Obesity and Insulin Resistance. Journal of Clinical Investigation, 95, 2409-2415. [Google Scholar] [CrossRef] 
[13] Makki, K., Froguel, P. and Wolowczuk, I. (2013) Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines. ISRN Inflammation, 2013, Article ID: 139239. [Google Scholar] [CrossRef] [PubMed]
[14] Lee, Y.S. and Olefsky, J. (2021) Chronic Tissue Inflammation and Met-abolic Disease. Genes & Development, 35, 307-328. [Google Scholar] [CrossRef] [PubMed]
[15] Ouchi, N., Par-ker, J.L., Lugus, J.J. and Walsh, K. (2011) Adipokines in Inflammation and Metabolic Disease. Nature Reviews Immu-nology, 11, 85-97. [Google Scholar] [CrossRef] [PubMed]
[16] Mulder, P., Morrison, M.C., Verschuren, L., Liang, W., van Bockel, J.H., Kooistra, T., Wielinga, P.Y. and Kleemann, R. (2016) Reduction of Obesity-Associated White Adipose Tissue Inflammation by Rosiglitazone Is Associated with Reduced Non-Alcoholic Fatty Liver Disease in LDLr-Deficient Mice. Scientific Reports, 6, Article No. 31542. [Google Scholar] [CrossRef] [PubMed]
[17] Cawthorn, W.P. and Sethi, J.K. (2008) TNF-Alpha and Adipocyte Biology. FEBS Letters, 582, 117-131. [Google Scholar] [CrossRef] [PubMed]
[18] Qatanani, M. and Lazar, M.A. (2007) Mechanisms of Obesi-ty-Associated Insulin Resistance: Many Choices on the Menu. Genes & Development, 21, 1443-1455. [Google Scholar] [CrossRef] [PubMed]
[19] Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. and Ferrante Jr., A.W. (2003) Obesity Is Associated with Macrophage Accumulation in Adipose Tissue. Journal of Clinical Investigation, 112, 1796-1808. [Google Scholar] [CrossRef] 
[20] Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A. and Chen, H. (2003) Chronic Inflammation in Fat Plays A Crucial Role in the Development of Obesity-Related Insulin Resistance. Journal of Clinical Investigation, 112, 1821-1830. [Google Scholar] [CrossRef] 
[21] Gao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L. and Bing, C. (2014) Interleukin-1β Mediates Macrophage-Induced Impairment of Insulin Signaling in Human Primary Adipocytes. American Journal of Physiology-Endocrinology and Metabolism, 307, E289-E304. [Google Scholar] [CrossRef] [PubMed]
[22] Ren, Y., Zhao, H., Yin, C., Lan, X., Wu, L., Du, X., Griffiths, H.R. and Gao, D. (2022) Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation. Frontiers in Endocrinology (Lausanne), 13, Article 873699. [Google Scholar] [CrossRef] [PubMed]
[23] Muñoz-Garach, A., Cornejo-Pareja, I. and Tinahones, F.J. (2016) Does Metabolically Healthy Obesity Exist? Nutrients, 8, Article 320. [Google Scholar] [CrossRef] [PubMed]
[24] Achari, A.E. and Jain, S.K. (2017) Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. International Journal of Molecular Sciences, 18, Article 1321. [Google Scholar] [CrossRef] [PubMed]
[25] Kumada, M., Kihara, S., Ouchi, N., Kobayashi, H., Okamoto, Y., Ohashi, K., Maeda, K., Nagaretani, H., Kishida, K., Maeda, N., Nagasawa, A., Funahashi, T. and Matsuzawa, Y. (2004) Adiponectin Specifically Increased Tissue Inhibitor of Metalloproteinase-1 through Interleukin-10 Expression in Human Macrophages. Circulation, 109, 2046-2049. [Google Scholar] [CrossRef] 
[26] Takemura, Y., Ouchi, N., Shibata, R., Aprahamian, T., Kirber, M.T., Summer, R.S., Kihara, S. and Walsh, K. (2007) Adiponectin Modulates Inflammatory Reactions via Calreticulin Receptor-Dependent Clearance of Early Apoptotic Bodies. Journal of Clinical Investigation, 117, 375-386. [Google Scholar] [CrossRef] 
[27] Ouchi, N., Higuchi, A., Ohashi, K., Oshima, Y., Gokce, N., Shibata, R., Akasaki, Y., Shimono, A. and Walsh, K. (2010) Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity. Science, 329, 454-457. [Google Scholar] [CrossRef] [PubMed]
[28] 李海霞, 魏静, 哈小琴. 抗炎性脂肪因子分泌型卷曲相关蛋白5参与炎性疾病的研究进展[J]. 中国生物制品学志, 2022, 35(5): 621-625+631. [Google Scholar] [CrossRef] 
[29] Tong, S., Ji, Q., Du, Y., Zhu, X., Zhu, C. and Zhou, Y. (2019) Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease. Journal of Interferon & Cytokine Research, 39, 472-482. [Google Scholar] [CrossRef] [PubMed]
[30] Karelis, A.D. and Rabasa-Lhoret, R. (2013) Obesity: Can Inflammatory Status Define Metabolic Health? Nature Reviews Endocrinology, 9, 694-695. [Google Scholar] [CrossRef] [PubMed]
[31] Appleton, S.L., Seaborn, C.J., Visvanathan, R., Hill, C.L., Gill, T.K., Taylor, A.W. and Adams, R.J, North West Adelaide Health Study Team (2013) Diabetes and Cardiovascular Disease Outcomes in the Metabolically Healthy Obese Phenotype: A Cohort Study. Diabetes Care, 36, 2388-2394. [Google Scholar] [CrossRef] [PubMed]
[32] Phillips, C.M. (2013) Metabolically Healthy Obesity: Definitions, Deter-minants and Clinical Implications. Reviews in Endocrine and Metabolic Disorders, 14, 219-227. [Google Scholar] [CrossRef] [PubMed]
[33] Lynch, L.A., O’Connell, J.M., Kwasnik, A.K., Cawood, T.J., O’Farrelly, C. and O’Shea, D.B. (2009) Are Natural Killer Cells Protecting the Metabolically Healthy Obese Patient? Obesity (Silver Spring), 17, 601-605. [Google Scholar] [CrossRef] [PubMed]

为你推荐